Terveystalo revenue and financials
€7.14Change from previous close: −4.55%Absolute change: −€0.34
In the fiscal year ended December 2025, Terveystalo reported revenue of €1.28B (−4.56% year over year). Net income was €92.6M, a net margin of 7.2%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −4.56%
- 2025 vs 2024
- Net income growth
- +29.15%
- 2025 vs 2024
- Net margin
- 7.2%
- 2024: 5.4%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 38.3 | -2.5 | 84.6 | 40.5 | 27.3 |
| Depreciation and amortization | 24.4 | 24.2 | 28.2 | 23.9 | 23.8 |
| Capital expenditure | -10.2 | -13.9 | -21.4 | -9.6 | -10.2 |
| Investing cash flow | -9.7 | -10.6 | -30.2 | -12.9 | -10.5 |
| Financing cash flow | -12.7 | 9.6 | -58.0 | -43.7 | -14.4 |
| Dividends paid | -40.6 | — | -30.4 | -30.4 | — |
| Debt issued | 48.5 | 29.6 | 0.0 | 8.1 | 0.0 |
| Debt repaid | 0.0 | -5.6 | -10.0 | 0.0 | 0.0 |
| Effect of exchange rates | — | — | 0.0 | — | 0.1 |
| Net change in cash | 15.9 | -3.5 | -3.6 | -16.1 | 2.4 |
| Free cash flow | 28.1 | -16.4 | 63.2 | 30.9 | 17.1 |